Edaravone and Acetovanillone Upregulate Nrf2 and PI3K/Akt/mTOR Signaling and Prevent Cyclophosphamide Cardiotoxicity in Rats.
Emad H M HassaneinOmnia A M Abd El-GhafarMarwa A AhmedAhmed M SayedWail M Gad-ElrabJamaan S AjaremAhmed A AllamAyman Moawad MahmoudPublished in: Drug design, development and therapy (2020)
AV and ED prevent CP cardiotoxicity by attenuating oxidative stress and tissue injury, and modulating cytoglobin, and PI3K/Akt/mTOR and Keap1/Nrf2 signaling. Therefore, AV and ED may represent promising agents that can prevent cardiac injury in patients receiving CP.